Executive Overview
Real-time operational metrics across 400+ global subsidiaries
▲ 12.4%
$94.2B
Total Revenue (TTM)
▲ 3.1%
400
Active Subsidiaries
▲ 5.8%
342K
Global Workforce
▲ 18.2%
$12.8B
R&D Investment
▼ 2.1%
98.7%
Operational Uptime
▲ 9.4%
89/100
ESG Compliance Score
Revenue Trend (Quarterly)
Revenue by Division
Recent Subsidiary Performance
View All →
| Subsidiary | Division | Status | Q3 Target |
|---|---|---|---|
| Zenth Digital Systems | Technology | On Track | 94.2% |
| Aevum Health Sciences | Healthcare | Review | 87.5% |
| Neo-Orbital Aerospace | Aerospace | Exceeded | 102.1% |
| Zenth Agritech | Agriculture | Delayed | 76.8% |
| Aevum Capital Group | Finance | On Track | 91.4% |
Live Activity Feed
Archive →
Zenth Health Sciences cleared Phase III FDA review for gene-therapy trial GZ-902.
12 min ago
Aevum Energy & Power completed smart-grid upgrade for 4M households in SE Asia.
1 hr ago
Robotics Labs deployed 12,000 new autonomous units to European logistics hubs.
3 hrs ago
Board Committee approved $2.4B capital allocation for Q4 R&D expansion.
5 hrs ago
Quick Actions
Approve Budget
Q4 Allocation Review
Sync Divisional Data
Last sync: 42 min ago
Schedule Audit
Compliance & ESG
Global Risk Report
Market & Geopolitical